vimarsana.com

Latest Breaking News On - Robert deluccia - Page 1 : vimarsana.com

Why Is Antibiotic Player Acurx Pharmaceuticals Stock Trading Lower Today? - Acurx Pharmaceuticals (NASDAQ:ACXP)

Acurx Pharmaceuticals' ibezapolstat outperforms vancomycin with a 94% eradication rate. Stay tuned for Q1 2024 updates on Extended Clinical Cure and microbiome data.

Curwensville board approves accelerated preliminary budget opt-out plan for Act 1 compliance

CURWENSVILLE — Curwensville Area School Board approved an accelerated 2024-25 budget opt-out resolution that includes certification the board would not increase taxes above the the inflation index set by the

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript November 14, 2023 Acurx Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-0.23952, expectations were $-0.28. Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief […]

Acurx Pharmaceuticals, Inc (NASDAQ:ACXP) Q3 2023 Earnings Call Transcript

Operator: Ladies and gentlemen, good morning, and welcome to the Acurx Pharmaceuticals Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Curwensville board adopts nearly $20M budget with no tax hike

CURWENSVILLE — Curwensville Area School Board unanimously adopted the proposed 2023-24 budget of nearly $20 million at its recent meeting. Property owners will not have a tax increase next year.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.